Skip to main content
. 2022 Mar 24;23(7):3535. doi: 10.3390/ijms23073535
TRT Testosterone Replacement Therapy
PADAM Partial Androgen Deficiency of the Aging Male
LOH Late-Onset Hypogonadism
LH Luteinizing hormone
COX2 cyclooxygenase-2
StAR steroidogenic acute regulatory protein
BMI Body Mass Index
AR androgen receptor
PPARγ Peroxisome Proliferator-Activated Receptor-gamma
CEBPα CAT/enhancer-binding protein alpha
IM intramuscular
RCT Randomized Clinical Trial
DHEA Dehydroepiandrosterone
DHEAS Dehydroepiandrosterone sulfate
BMD bone mineral density
IIEF International Index of Erectile Function
EFD Erectile Function Domain
PDE-5i phosphodiesterase type 5 inhibitors
SAID Sexual Arousal, Interest and Drive Scale
HED Hypogonadism Energy Diary
T2DM Type 2 diabetes mellitus
HbA1c glycated hemoglobin
HOMA-IR homeostatic model assessment of insulin resistance
IL-18 interleukin 18
ADT Androgen deprivation therapy
CV cardiovascular
FDA Food and drug administration
QoL Quality of life
AMS Aging Males’ Symptom
ED Erectile dysfunction